Skip to main content
InspireMD, Inc. logo

InspireMD, Inc. — Investor Relations & Filings

Ticker · NSPR ISIN · US45779A8466 LEI · 549300OQ16IJ5DIS5D30 US Manufacturing
Filings indexed 1,106 across all filing types
Latest filing 2026-05-07 Interim / Quarterly Rep…
Country US United States of America
Listing US NSPR

About InspireMD, Inc.

https://www.inspiremd.com/en/

InspireMD, Inc. is a commercial-stage company focused on developing and commercializing technologies for stroke prevention through advanced carotid intervention. The company's core technology is its proprietary MicroNet™ platform, a non-metallic mesh designed to prevent plaque prolapse and embolization. Its flagship product, the CGuard® Prime Carotid Stent System, integrates this MicroNet mesh with a self-expanding nitinol stent. This dual-layered design provides neuroprotection by trapping potential emboli during and after carotid artery stenting procedures. The system is indicated for improving carotid luminal diameter in patients who require carotid revascularization and are at high risk for adverse events from carotid endarterectomy.

Recent filings

Filing Released Lang Actions
10-Q - InspireMD, Inc. (0001433607) (Filer)
Interim / Quarterly Report
2026-05-07 English
ARS - InspireMD, Inc. (0001433607) (Filer)
Annual Report
2026-04-20 English
8-K - InspireMD, Inc. (0001433607) (Filer)
Regulatory Filings
2026-04-03 English
424B5 - InspireMD, Inc. (0001433607) (Filer)
Prospectus
2026-04-03 English
10-K - InspireMD, Inc. (0001433607) (Filer)
Annual Report FY 2025
2026-03-18 English
SCHEDULE 13G Filing
Major Shareholding Notification
2026-02-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.